Industrial-scale bioreactors for large-scale biomanufacturing
When producing at large volumes, efficient and reliable bioprocess systems are crucial for ensuring consistent quality of biopharmaceuticals and alternative proteins while minimizing downtime.
Processes Large-Scale Bioproduction with Automation
The AUXO V® bioreactors from n!Biomachines Ltd. are engineered-to-order systems ideal for biomanufacturers seeking reliable scalability and automation in bioproduction. Specifically designed to handle capacities exceeding 5000 liters, these bioreactors are perfect for producing biopharmaceuticals, nutraceuticals, plant-based products, and cultivated meats. The bioreactors integrate advanced automation and remote monitoring, reducing downtime while boosting productivity. Featuring robust construction, they are well-equipped to manage the demands of continuous industrial-scale operations. The stainless steel construction ensures chemical compatibility and longevity. With PLC-controlled systems, these units offer seamless integration into existing production lines and support the upscaling of bioprocesses efficiently. Compliance with industry standards such as GMP ensures they are suitable for pharmaceutical applications. Moreover, the bioreactors include CIP (Clean-In-Place) systems for maintaining contamination-free operations. Tailor the bioreactors to your specific needs with a variety of customization options provided by n!Biomachines Ltd.’s engineering support.
Benefits
- Increases production capacity with high-volume processing up to 5000 liters.
- Minimizes operational downtime through robust construction and remote monitoring.
- Enhances process consistency and efficiency with advanced automation and scalability.
- Ensures regulatory compliance and product safety with GMP-standard design.
- Simplifies maintenance and reduces contamination risk with integrated CIP systems.
- Applications
- Alternative proteins,Nutritional supplements,Nutraceuticals,Plant-based products,Biopharmaceuticals,Healthcare products,Cultivated meat
- End products
- Tissue-engineered skin grafts,Plant-based meat substitutes,Cultivated chicken meat,Omega-3 fatty acids,Human insulin,Monoclonal antibodies,Protein powder supplements,Plant-based milk
- Steps before
- Cell culture preparation,Media formulation,Inoculation
- Steps after
- Harvesting,Purification,Protein extraction
- Input ingredients
- biomass,nutrients,culture media
- Output ingredients
- bioproducts,proteins,cultivated meat
- Market info
- Capacity
- Exceeds 5000 liters
- Automation
- Advanced automation systems
- Durability
- Robust and durable construction
- Scalability
- Designed for large-scale production
- Monitoring
- Remote and on-site monitoring
- Automation level
- Advanced automation systems
- Batch vs. continuous operation
- Batch
- High-volume capacity
- 5000+ liters
- Scalability
- Adaptable to increasing production demands
- Remote and on-site monitoring
- Yes
- Durability
- Robust and durable construction
- Density/particle size
- 0.5–2.5 g/cm³ / 50–1000 µm
- Volume Capacity
- 5000 liters+
- Construction Material
- Durable materials for industrial conditions
- Customization Options
- Fit-for-purpose configuration
- Monitoring
- Remote and on-site
- Footprint
- Compact for large-scale machinery
- Capacity options
- Exceeds 5000 liters
- Automation level
- Advanced automation systems
- Scalability
- Adaptable to increasing production demands
- Customization options
- Fit-for-purpose bioreactors
- Monitoring type
- Remote and on-site